REGN Regeneron Pharmaceuticals Inc.

High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023

High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023

$75,000 Top Award Goes to 17-year-old Kaitlyn Wang for breakthrough innovation to accelerate exoplanet discovery in the largest international STEM competition for teens

TARRYTOWN, N.Y. and WASHINGTON, D.C., May 19, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and (the Society) announced that Kaitlyn Wang, 17, of San José, CA, won the $75,000 top award in the 2023 (Regeneron ISEF), the world’s largest global pre-college science and engineering competition, for a project that explored planets that orbit very close around their suns. Other top prizes went to projects in the fields of computational biology, animal sciences and neurobiology.

The top winners were honored during two award ceremonies, the first of which took place on the evening of May 18 and featured . The Grand Awards Ceremony was held on the morning of May 19 and included the announcement of the top prize of $75,000. In total, nearly U.S. $9 million was awarded to the finalists, who were evaluated based on their projects’ creativity, innovation and depth of scientific inquiry. The competition featured over 1,600 young scientists representing 49 states and 64 countries across the world.

won first place and received the $75,000 , named in honor of the pioneering drug researcher and Regeneron co-founder, President and Chief Scientific Officer, for finding an efficient way to identify certain exoplanets that orbit very closely around their stars. Previous techniques used to detect these ultra-short-period planets required enormous computational power but were not as effective at identifying these planets. Kaitlyn surmounted that problem by creating a special algorithm that runs on cheap hardware and results in much faster and higher-precision findings. Using her research, she says she found the smallest of these planets ever discovered.

, 17, of Columbia, Missouri, received one of two of $50,000 for using biocomputational methods to understand the causes of heightened infectivity in the disease mpox after it reemerged in 2022. Saathvik’s approach, named Bioplex, uses a combination of machine learning and three-dimensional comparative protein modeling to decode structures like those that enable the mpox virus to replicate. This allowed him to identify the mutations in the virus that likely made it more infectious as well as other mutations that could make it resistant to antibiotics. Saathvik believes scientists will also be able to apply Bioplex to future outbreaks of other viruses.

, 17; Pannathorn Siri, 16; and, Poon Trakultangmun, 18, of Bangkok, Thailand, received the second of $50,000 for developing an innovative incubation chamber that promotes the survival of the green lacewing insect, a natural predator of the mealybug, a harmful pest. In nature, the green lacewing has a low survival rate, but the team’s new system increased the lacewing’s survival rate five-fold. In field tests, their incubation system was an effective alternative to insecticides and lowered the mealybug population density nearly four-fold.

“Congratulations to the Regeneron International Science and Engineering Fair 2023 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I am humbled by the creativity and determination demonstrated by these exceptional students and proud of all they have accomplished with their outstanding research abilities. Together, these students from various academic disciplines and geographies are solving the world’s most intractable problems."

Regeneron ISEF provides a global stage for the best and brightest young scientists and engineers around the world. Through this competition Regeneron and the Society support and invest in the next generation of leading STEM innovators who are generating ideas and acting as catalysts for the change needed to improve the well-being of all people, society and the planet.

“We are thrilled to celebrate this year's Regeneron ISEF finalists as they join our growing community of bold individuals tackling the world’s most pressing challenges,” said George D. Yancopoulos, M.D., Ph.D., co-founder, President and Chief Scientific Officer of Regeneron. “I applaud today’s finalists and all the ISEF participants for their relentless pursuit of groundbreaking ideas that ignite positive and sustainable change in our world. I owe so much of my passion for science to the experiences and mentors I had in high school, and I hope that today is just the beginning of a lifelong commitment to STEM for many of these students.”

Other top honors from the competition include:

, 16, of Jericho, New York, received the of $50,000 for Positive Outcomes for Future Generations for her search for biomarkers to help prevent suicides. By analyzing de-identified brain tissue from 20 people, Natasha measured levels of two proteins, cytokine and claudin-5, and found that neuroinflammation and claudin-5 were increased in the brains of suicide cases. Her work suggests that high levels of the protein claudin-5 could serve as pre-markers for suicide and that certain anti-inflammatory drugs might decrease claudin-5 levels.

, 16, of Shanghai, China, received the of $10,000 for his development of an inchworm-style stick-climbing robot. This type of robot conventionally has grabbers that allow it to climb over and under obstructions like a caterpillar does, but he added skateboard-like wheels, which allow it to perform better than existing inchworm-style robots when the angle is less than 22°. The hybrid wheel/grabber assembly is novel, and he believes his robot will work well for tasks that are potentially dangerous to humans, such as inspecting damaged high-voltage lines.

, 17, and Gopalaniruddh Tadinada, 17, of Louisville, Kentucky, received the of $10,000 for building a custom, automated system to detect gastrointestinal cancer before serious symptoms appear. The team’s system combines robotics and machine learning to analyze blood samples to identify healthy patients, as well as those with pancreatic, colorectal or hepatic cancers, in only three hours at an estimated cost of only $300. Detecting these cancers before they metastasize could make treatment much simpler and more effective.

, 16, of Shanghai, China, received the of $10,000 for his inexpensive energy-saving device that recycles the condensation produced by air conditioners to improve their energy efficiency. His device directs the cooling fan’s airflow to spray the air conditioner’s condensation at its own condenser, lowering its temperature and thus reducing power consumption and improving its energy efficiency. Eugene believes his easy-to-install device can reduce the amount of electricity used by air conditioners by more than 10%.

More information about the top winners and visual assets can be found at 

Daniel Levin, 18, of Pittsburgh, Pennsylvania; Alexander Plekhanov, 17, of Portland, Oregon; and Kevin Zhu, 18, of Old Westbury, New York received the Dudley R. Herschbach SIYSS Award, which provides the finalists with an all-expenses-paid trip to attend the Stockholm International Youth Science Seminar, which includes attendance at the Nobel Prize Ceremonies in Stockholm, Sweden.

George Cheng, 17, of Cary, North Carolina, and Yik Chun John Peng, 17, of Shanghai, China received the EU Contest for Young Scientists Award, which is presented to two projects that will represent Regeneron ISEF at the EU Contest for Young Scientists to be held in Brussels, Belgium, September 13-17, 2023.

In addition to the Top Award winners, 450 finalists received awards and prizes for their innovative research, including “First Award” winners, who each received a $5,000 prize. The following lists the First Award winners for each of the 21 categories, from which the Top Awards were chosen:

Category and SponsorWinnerLocation
Animal Sciences, sponsored by Society for Science

Teepakorn KeawumdeeBangkok, Thailand

Pannathorn Siri
Poon Trakultangmun
Behavioral and Social Sciences, sponsored by Society for ScienceEmma Colarte DelgadoSouthwest Ranches, FL
Biochemistry, sponsored by RegeneronHarrison Hao-Tian TangShanghai, China
Biomedical and Health Sciences, sponsored by Regeneron

Natasha KulviwatJericho, NY
George ChengCary, NC
Biomedical Engineering, sponsored by Society for Science

Rishabh RanjanLouisville, KY

Gopalaniruddh Tadinada
Muhammad El-SherbinyFort Lee, NJ
Cellular and Molecular Biology, sponsored by RegeneronSarah JenningsOssining, NY
Chemistry, sponsored by Beal Bank

Ekin AsyaliGaziantep, Turkey

Sude Gulsen
Faisal Almuhaysh

Hofuf, Saudi Arabia
Computational Biology and Bioinformatics, sponsored by Regeneron

Saathvik KannanColumbia, MO
Kevin ZhuOld Westbury, NY
Earth and Environmental Sciences, sponsored by National Geographic Society

Franziska BorneffRoanoke, VA
Paige HinkleSinking Spring, PA
Embedded Systems, sponsored by MicrosoftYik Chun John PengShanghai, China
Energy: Sustainable Materials and Design, sponsored by Siemens EnergyEugene ChenShanghai, China
Engineering Technology: Statics and Dynamics, sponsored by Howmet Aerospace Foundation

Yuyang WangShanghai, China
Ethan ZentnerGlendale, WI
Environmental Engineering, sponsored by Jacobs

Mohammed AlarfajAl Khobar, Saudi Arabia
Aryan MagoShrewsbury, MA
Materials Science, sponsored by Howmet Aerospace FoundationCalvin MathewDavie, FL
Mathematics, sponsored by Akamai FoundationMeryl ZhangPlano, TX
Microbiology, sponsored by Robert I. Schattner Foundation

Shriya BhatRichardson, TX
Daniel LevinPittsburgh, PA
Physics and Astronomy, sponsored by Richard F. Caris Charitable Trust II

Alexander PlekhanovPortland, OR
Kaitlyn WangSan José, CA
Plant Sciences, sponsored by Society for ScienceDongtian LiuShanghai, China
Robotics and Intelligent Machines, sponsored by Regeneron

Timucin ErbasActon, MA
Kai TurnerSydney, Australia
Systems Software, sponsored by MicrosoftHarshil AvlaniChandler, AZ
Translational Medical Science, sponsored by Regeneron

Aditi AvinashCastle Pines, CO
Alanna PolyakPlano, TX



View all the finalists’ research .

About the Regeneron International Science and Engineering Fair

The Regeneron International Science and Engineering Fair (Regeneron ISEF), a program of Society for Science for over 70 years, is the world’s largest global science competition for high school. Through a global network of local, regional and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately U.S. $9 million in awards and scholarships.

In 2019, Regeneron became the title sponsor of ISEF to help reward and celebrate the best and brightest young minds globally and encourage them to pursue careers in STEM as a way to positively impact the world. Regeneron ISEF is supported by a community of additional sponsors, including Akamai Foundation; Beal Bank; Gordon and Betty Moore Foundation; Howmet Aerospace Foundation; Jacobs; King Abdulaziz & his Companions Foundation for Giftedness & Creativity; Lyda Hill Philanthropies; Microsoft; National Geographic Society; Richard F. Caris Charitable Trust II; Rise, an initiative of Schmidt Futures and the Rhodes Trust; Robert I. Schattner Foundation; Siemens Energy; Texas A&M Engineering; Perot Museum; Cesco Linguistic Services; Insaco; Oracle Academy; Southern Methodist University; The University of Texas at Dallas; Army ROTC; ExxonMobil; and The Hoglund Foundation. ISEF alumni have gone on to have world-changing careers in science and engineering and earn some of the most esteemed honors, including the National Medal of Science, MacArthur Foundation Fellows, National Academy of Sciences and National Academy of Engineering Inductees. Many are entrepreneurs across a wide range of industries. Learn more at .

About Society for Science

Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at  and follow us on , ,  and Snapchat (Society4Science).

About Regeneron

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Regeneron’s medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.

Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the United States. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro-bono and matching gift programs. Our most significant philanthropic commitments are in the area of science education, including the  and .

For additional information about the company, please visit or follow @Regeneron on Twitter.

Media Contacts

Joseph Brown, Regeneron

386-283-1323, 

Gayle Kansagor, Society for Science

703-489-1131,

 



EN
19/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Regeneron Pharmaceuticals Inc.

 PRESS RELEASE

Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Mye...

Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ≥70% despite limited follow-up; evidence shows that these responses are expected to deepen over time Across all dose groups, 95% (19 of 20 patients) of all evaluable VGPR+ patients achieved minimal residual disease negative status Data featured in an ASH oral presentation;...

 PRESS RELEASE

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Inv...

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 million, inclusive of a cash upfront and equity investment from Regeneron; companies to share worldwide development costs and future profits 50:50Collaboration combines Regeneron’s long-standing expertise in genetics, genetic medicines and clinical develop...

 PRESS RELEASE

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the E...

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU) Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite standard-of-care antihistamine treatment Dupixent, which inhibits IL-4 and IL-13, two key and central drivers of type 2 inflammation, is now approved for patients across seven chronic, inflamm...

 PRESS RELEASE

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatme...

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing flexibility for more personalized patient care TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has...

 PRESS RELEASE

Libtayo® (cemiplimab) Approved in the European Union as First and Only...

Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of recurrence or death by 68% (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51; p

ResearchPool Subscriptions

Get the most out of your insights

Get in touch